1. It needs to be confirmed that parenteral antibiotics are truly required and that effective oral therapy cannot be given. Many conditions such as pneumonia and osteomyelitis can be effectively managed with oral antibiotics.
2. The patient needs to be well enough to be at home. Comorbidities such as unstable diabetes, relative hypoxaemia, severe pain, cognitive dysfunction and visual or auditory handicap are contraindications.
3. The patient has to be willing to accept the program. Obligations of the patient and program of care should be discussed with the patient and carer.
4. The home environment must be suitable. There needs to be a clean, light area where intravenous line access can be performed. There also needs to be a refrigerator, telephone and a carer who is able to contact the program in an emergency.
5. Distance of the patient's home from the treating centre needs to be taken into account in terms of frequency of visits.
6. A clear understanding of medical responsibility is essential. Many programs have their own medical staff and patient care responsibility is transferred to a doctor working in the program. Other programs are led by non-medical healthcare professionals and medical responsibility remains with the referring doctor.
7. Home care should never be accepted when it is second best to inpatient management. Transfer to a home program when a patient threatens selfdischarge is strongly discouraged. Reasons for the patient's desire to self-discharge against advice should be carefully sought and advice to remain in hospital should be communicated in a culturally appropriate and non-judgemental fashion.
8. The presence of substance abuse such as alcoholism or illicit drugs is a contraindication.
introduction
Outpatient intravenous antimicrobial therapy has been practised in the USA since the 1970s and in Australia since the mid-1990s. A number of infections, such as acute cellulitis, lower respiratory tract infections and exacerbations of bronchiectasis, osteomyelitis and infective endocarditis, can now be treated safely at home.
Many infections can be treated orally. However, because of increasing antibiotic resistance, many infections that were once treated with oral antibiotics have to be treated parenterally.
Models of care
A number of programs for home-based therapy have been developed. They can be roughly divided into three categories:
• healthcare professionals visit a patient's home regularly to administer therapy
• patient administers their own therapy at home after successful training
• patient attends regular appointments at the hospital for treatment.
The first category, in which nurses and other health professionals visit patients to administer treatment, dominates in Australia and was first adopted in Victoria in 1994. 1 Other programs do exist and the patient self-administration model is an attractive option in Australia given large geographical areas 
indications for home intravenous therapy
Only a small number of bacterial infections need to be treated with intravenous antibiotics in the home. Many mild to moderate infections can be effectively treated with oral antibiotics. For example, mild to moderate pneumonia can generally be treated orally, and even more severe cases can be changed from intravenous medications to oral once the patient is stable. 2 Similarly, urosepsis such as pyelonephritis can often be treated with oral drugs initially if the patient is stable and not vomiting, or changed to oral therapy once stable and the microbiology results are available. 2 Streptococcal cellulitis often does not respond to oral therapy, and in the absence of severe sepsis or comorbidity it is a suitable condition for initial intravenous antibiotics at home (Table 1) . For example, once-daily intravenous cefazolin plus oral probenecid is effective for moderate to severe cellulitis. 3 Patients who have been treated and stabilised in hospital and require prolonged courses of intravenous antibiotics are commonly treated at home. Examples of indications include infective endocarditis, osteomyelitis, infected prosthetic material, brain, lung and liver abscess, exacerbations of bronchiectasis or cystic fibrosis, and specific diseases such as melioidosis. Examples of intravenous antibiotic regimens given at home are listed in Table 1 . 
Antibiotic resistance

Antibiotic selection
When choosing an antibiotic, evidence-based guidelines should be followed. 2 Only when the preferred therapy cannot be given in the home should an alternative broad spectrum drug be used.
The resources of the home program may affect the choice of antibiotic. In practice, most services will only be able to visit a patient once a day, few can visit more often. The two key factors in assessing whether an antibiotic is appropriate for use in a home program are drug stability and administration intervals. Other factors, including toxicity and whether adequate monitoring is possible, are also important.
Stability
Antibiotics must be sufficiently stable for the duration of the infusion or for extended periods if manufactured in advance. Stability is usually defined as greater than 90% of the original concentration remaining at the end of the infusion. Ampicillin and Twice-daily infusions of vancomycin or similar can be managed using programmable continuous ambulatory delivery pumps where the day's supply of vancomycin is delivered as two infusions 12 hours apart. Given the practicalities of many home services however, continuous infusions are often used and evidence is emerging that this method is satisfactory although comparative trials are lacking.
Monitoring
Monitoring patients enrolled in home programs is crucial to maximise efficacy and minimise toxicity. Therapeutic drug monitoring should be undertaken at least weekly for vancomycin and usually more often for aminoglycosides. There are very few indications such as multidrug resistant tuberculosis that warrant long-term aminoglycoside treatment and alternative antibiotics should always be used if appropriate. Aminoglycoside toxicity is related to duration of therapy and patients being treated for longer than five days are at significantly increased risk of both renal and vestibular ototoxicity. Close monitoring including weekly audiometry is recommended. Therapeutic drug monitoring is available throughout Australia for other antibiotics including beta-lactams and teicoplanin, and may be useful in certain patients upon specialist advice.
amoxicillin are commonly used in hospitals but are unsuitable for home programs given their low stability in aqueous solution. 4 The stability of many antibiotics is temperature dependent and whilst they may be stable in a refrigerator for extended periods they can rapidly degrade at room and body temperature. This is an important consideration when giving continuous infusions. During an infusion, temperatures can reach more than 31˚ C. 5, 6 Benzylpenicillin, for example, is a useful antibiotic to treat many streptococcal and enterococcal infections. However unless the antibiotic is compounded using a buffer, it rapidly degrades with 1-5% remaining after 24 hours at body temperature. 6, 7 Meropenem, a carbapenem drug that is often required to treat multidrug resistant pathogens, is poorly stable in solution and is unsuitable for continuous infusions. 8 A strategy where it is compounded and kept in the patient's refrigerator, then given eighthourly rather than as a continuous infusion, helps overcome this problem. Continuous infusion with the bag of meropenem inside an ice pack has also been attempted. A large body of information exists on drug stability and specialty pharmacy services may be able to assist.
Administration intervals
If the patient can only be visited once a day, prescribing of antibiotics is limited to either oncedaily bolus dosing or 24-hour infusions. The optimal method of administering an antibiotic will depend upon the pharmacological properties of the drug which can be separated into three categoriesconcentration-dependent killing, total exposure and time-dependent killing ( Table 2) .
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Conclusion
The treatment of infections with intravenous antibiotics in the home is an established treatment modality. Careful patient selection, safe intravenous access and appropriate training and monitoring means that many patients can be treated at home.
Unfortunately, the rise of multidrug resistant infections means more patients will need prolonged courses of intravenous antibiotics.
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